Faculty & Research

The Department of Neurology has a strong tradition of both basic and clinical research and our faculty includes many nationally and internationally recognized clinician-researchers with active research programs. The Department consistently ranks as one of the top neurology departments in the United States for extramural research funding from the National Institutes of Health. With recent recruitment into the areas of neurocritical care, stroke general neurology and neuroimmunology, the Department has grown to over 140 faculty including over 74 full-time clinical faculty as well as faculty from other departments holding either secondary or adjunct appointments. There are a broad range of research activities being carried out across the 14 divisions and centers associated with the Department of Neurology. Eight primary faculty in the department run NIH funded basic research programs and over 40 faculty members participated in one or more NIH or industry sponsored research trials in 2013 alone.

The Neuroscience community at the University of Rochester is highly interdisciplinary and diverse reflected by a large group of investigators including over 60 faculty members across ten different departments from the School of Medicine and College of Arts and Sciences. Over the past 15 years, the institution has continued to make substantive investments in research including the opening of the Kornberg medical research building and the MRB-extension (MRBX) in 1998 and 2002, which currently house both the Center for Neural Development and Disease as well as the Center for Translational Neuromedicine. The URMC was also one of the first sites selected in 2006 to build the Clinical and Translational Science Institute, which houses both the Center for Human Experimental Therapeutics as well as the Clinical Trials Coordination Center. 

The University of Rochester continues to demonstrate excellence in the areas of biomedical and clinical research.  In addition to having 8 faculty receive the Nobel Prize, the University of Rochester Medical Center (URMC) has been the home for a number of transformative medical discoveries including the medical use of surfactant, the discovery of Cox-2, and the development of vaccines for HiB and HPV. Overall, UR ranked 32nd in federally financed research and development expenditures to academic institutions in 2013. US News & World Reports 2014 Best Hospitals guidebook ranked URMC Neurology and neurosurgery 29th in the country out of a total of nearly 5000 eligible hospitals.